Services offered by the Vaccine Evaluation and Development Centre (VDEC)
We use decades of experience in safe bioagent handling to support partners in research, development and testing of vaccines and therapeutics
Our VDEC services
The Vaccine Development and Evaluation Centre (VDEC) supports scientists at every stage of the vaccine and therapeutic medicine development process.
Our services are accredited to ISO 9001:2015, good laboratory practice (GLP) good clinical practice (GCP) or good manufacturing practice (GMP) quality standards as appropriate.
Work with VDEC
We work with industry, academia and government. Contact UKHSA today to see how we can help you.
Our working areas
Discovery and surveillance
- bacterial and viral isolation
- preparation of characterised bacterial and viral stocks
- antigen discovery for novel and emerging viruses and bacterial pathogens
- recombinant protein expression, purification and characterisation
- antimicrobial discovery and evaluation
See more information about our discovery services.
Antimicrobial resistance (AMR)
- preventing AMR arising during treatment
- combating or reversing existing drug resistance
- reducing drug toxicity and treatment times
- tackling multidrug-resistant gram-negative infections
See more information about our AMR services.
Pre-clinical
- pre-clinical in vivo model development for infectious diseases
- pathogen challenge models, protective efficacy studies and immunogenicity testing
- advanced imaging including MRI in-life PET-CT and CT scanning
- organ-on-a-chip or micro-physiological systems research
- pathology and histopathology services
- medical countermeasure testing
- provision of data for regulatory submissions
See more information about our pre-clinical services.
Clinical
- development, characterisation and validation of immuno assays for clinical evaluation (Phase I-III)
- virus neutralisation and pseudovirus assays, enzyme-linked immunosorbent assays (ELISAs), multiplexed and functional cell-based assays
- high throughput serology assays for emerging pathogens
- provision of data for regulatory submissions
See more information about our clinical services.
Post-licensure
- phase IV study support
- provision of data for regulatory submissions
See more information about our post-licensure services.
Other services
- biosafety and infection control services
- high-containment laboratory and outbreak response training
Scientist conducting an immunoassay
Who we work with
We work collaboratively with partners in
- government
- academic institutes
- non-governmental organisation (NGO) funding bodies
- life science companies
Updates to this page
Published 20 May 2024Last updated 16 July 2024 + show all updates
-
Added the VDEC form link.
-
First published.